At first glance, some people seem to have recovered from COVID-19. They no longer test positive and can return to work or ...

A team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could ...

Reflecting on my career as a physician-scientist, I’m reminded of guiding reasons why this path has aligned my interests and strengths. In my practice, I balance caring for bladder and kidney cancer ...

AbbVie is acquiring Capstan Therapeutics, a startup with technology that enables in vivo engineering of immune cells.

PORTLAND, IA, UNITED STATES, July 1, 2025 /EINPresswire.com/ -- According to the report, the "peptone market" was valued at $135.2 million in 2019, and is estimated to reach $240.5 million by 2035, ...

Insects possess a remarkable ability to develop innate immune memory, and the mechanisms underlying this process are becoming a central topic in innate immunity research.

Advanced imaging technologies are uncovering surprising roles for CD8+ T cells—not just in immune defense, but also in supporting tissue repair and regeneration.

As part of the deal, AbbVie will acquire Capstan's targeted LNP platform technology and its lead candidate for B cell-mediated autoimmune diseases.

AbbVie ABBV announced that it has entered into a definitive agreement to acquire privately held biotech, Capstan Therapeutics ...

In the fight against cancer, immunotherapy - which aims to boost the body's natural defences against cancer - is experiencing remarkable growth. Most of these treatments are based on CD8 T lymphocytes ...

AbbVie’s $2.1 billion acquisition of Capstan Therapeutics aims to advance in vivo CAR-T therapies, transforming autoimmune ...

Sean Dunne, of Shenandoah (Bloomsburg campus); and Adam Seasholtz, Selinsgrove (Lock Haven campus) presented their research ...